Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Biol Reprod ; 100(6): 1597-1604, 2019 06 01.
Article in English | MEDLINE | ID: mdl-30951583

ABSTRACT

Matrix metalloproteinases 2 and 9 (MMP2/9) have previously been shown to be elevated in serum and amniotic fluid from women undergoing preterm birth. We performed experiments to determine the effects of MMP2/9 on uterine contraction and birth timing. Pregnant mice were injected daily with 50 mg/kg of SB-3CT or vehicle control beginning on gestational day 14-18 to determine if MMP2/9 inhibition would affect parturition timing. MMP2/9 expression in human myometrial tissue was determined by Simple Western (Wes) and semiquantitative western blot. Purified MMP2/9 and SB-3CT inhibitor were added to human myometrial strips to determine the effects of MMP2/9 on oxytocin-induced uterine contraction. Parturition was delayed in mice treated with MMP2/9 inhibitor SB-3CT. MMP2/9 protein levels were elevated in preterm laboring uterine myometrium. Gelatinase activity was confirmed in cell extracts and supernatants from immortalized and primary human uterine myometrial cells in culture. Addition of purified MMP2/9 increased the oxytocin-induced contractile response in myometrial tissue strips from pregnant women. In contrast, addition of the MMP2/9 inhibitor SB-3CT decreased the contractile response to oxytocin in a dose-dependent manner. These results suggest abnormal MMP2/9 expression affects the contractile state of the uterine myometrium to promote parturition and that MMP2/9 inhibition attenuates this effect.


Subject(s)
Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Myometrium/metabolism , Obstetric Labor, Premature/metabolism , Uterine Contraction/metabolism , Adult , Animals , Cells, Cultured , Disease Progression , Female , Heterocyclic Compounds, 1-Ring/pharmacology , Humans , Matrix Metalloproteinase 2/pharmacology , Matrix Metalloproteinase 9/pharmacology , Mice , Mice, Inbred C57BL , Myometrium/drug effects , Myometrium/pathology , Obstetric Labor, Premature/pathology , Oxytocin/pharmacology , Parturition/physiology , Pregnancy , Sulfones/pharmacology , Uterine Contraction/drug effects , Uterine Contraction/physiology , Uterus/drug effects , Uterus/metabolism , Uterus/pathology , Young Adult
2.
J Biomech ; 73: 99-107, 2018 05 17.
Article in English | MEDLINE | ID: mdl-29661501

ABSTRACT

Mechanical strain associated with the expanding uterus correlates with increased preterm birth rates. Mechanical signals result in a cascading network of protein phosphorylation events. These signals direct cellular activities and may lead to changes in contractile phenotype and calcium signaling. In this study, the complete phospho-proteome of uterine smooth muscle cells subjected to mechanical strain for 5 min was compared to un-strained controls. Statistically significant, differential phosphorylation events were annotated by Ingenuity Pathway Analysis to elucidate mechanically induced phosphorylation networks. Mechanical strain leads to the direct activation of ERK1/2, HSPB1, and MYL9, in addition to phosphorylation of PAK2, vimentin, DOCK1, PPP1R12A, and PTPN11 at previously unannotated sites. These results suggest a novel network reaction to mechanical strain and reveal proteins that participate in the activation of contractile mechanisms leading to preterm labor.


Subject(s)
Myocytes, Smooth Muscle/cytology , Myocytes, Smooth Muscle/metabolism , Phosphoproteins/metabolism , Proteomics , Stress, Mechanical , Uterus/cytology , Adult , Animals , Biomechanical Phenomena , Female , Humans , Mechanotransduction, Cellular , Muscle Contraction , Phosphorylation , Uterus/physiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL